Huafon Chemical Co.,Ltd (SHE:002064)
China · Delayed Price · Currency is CNY 10.99
+0.27 (2.52%)
Apr 8, 2026, 3:04 PM CST
Huafon Chemical Co.,Ltd Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 22,529 | 25,002 | 23,447 | 23,736 | 27,221 |
Other Revenue | 1,670 | 1,929 | 2,851 | 2,148 | 1,146 |
| 24,198 | 26,931 | 26,298 | 25,884 | 28,367 | |
Revenue Growth (YoY) | -10.15% | 2.41% | 1.60% | -8.75% | 92.66% |
Cost of Revenue | 21,018 | 23,215 | 22,273 | 21,332 | 17,388 |
Gross Profit | 3,180 | 3,717 | 4,026 | 4,552 | 10,979 |
Selling, General & Admin | 618.7 | 620.16 | 624.33 | 618.33 | 595.68 |
Research & Development | 637.76 | 809.38 | 901.43 | 1,062 | 1,026 |
Other Operating Expenses | -28.17 | -38.23 | 66.36 | 108.1 | 177.83 |
Operating Expenses | 1,241 | 1,392 | 1,611 | 1,792 | 1,818 |
Operating Income | 1,939 | 2,325 | 2,414 | 2,760 | 9,161 |
Interest Expense | -57.01 | -118.37 | -166.43 | -140.66 | -137.07 |
Interest & Investment Income | 337.72 | 389.45 | 444.3 | 390.47 | 218.03 |
Currency Exchange Gain (Loss) | -14.45 | 1.1 | -29.18 | 67.1 | -36.01 |
Other Non Operating Income (Expenses) | -70.46 | -60.68 | -10.37 | -62.04 | -71.85 |
EBT Excluding Unusual Items | 2,135 | 2,536 | 2,653 | 3,015 | 9,134 |
Impairment of Goodwill | - | - | - | - | -29.47 |
Gain (Loss) on Sale of Investments | 18.23 | 2.34 | -2.78 | -2.34 | -1.33 |
Gain (Loss) on Sale of Assets | -4.81 | 2.6 | -4.05 | -3.67 | -13.74 |
Asset Writedown | -1.12 | -171.8 | -41.89 | -3.12 | -24.12 |
Other Unusual Items | -13.7 | 144.28 | 14.77 | 175.39 | 91.25 |
Pretax Income | 2,134 | 2,514 | 2,619 | 3,181 | 9,156 |
Income Tax Expense | 262.33 | 286.76 | 139.69 | 339.41 | 1,220 |
Earnings From Continuing Operations | 1,871 | 2,227 | 2,479 | 2,842 | 7,936 |
Minority Interest in Earnings | -13.91 | -6.88 | -0.72 | 2.03 | 0.52 |
Net Income | 1,858 | 2,220 | 2,478 | 2,844 | 7,937 |
Net Income to Common | 1,858 | 2,220 | 2,478 | 2,844 | 7,937 |
Net Income Growth | -16.32% | -10.43% | -12.85% | -64.17% | 248.23% |
Shares Outstanding (Basic) | 4,963 | 4,963 | 4,963 | 4,880 | 4,634 |
Shares Outstanding (Diluted) | 4,963 | 4,963 | 4,963 | 4,880 | 4,634 |
Shares Change (YoY) | - | - | 1.69% | 5.33% | -0.38% |
EPS (Basic) | 0.37 | 0.45 | 0.50 | 0.58 | 1.71 |
EPS (Diluted) | 0.37 | 0.45 | 0.50 | 0.58 | 1.71 |
EPS Growth | -17.29% | -10.43% | -13.89% | -66.08% | 248.98% |
Free Cash Flow | 2,023 | 1,731 | 752.07 | -36.69 | 4,020 |
Free Cash Flow Per Share | 0.41 | 0.35 | 0.15 | -0.01 | 0.87 |
Dividend Per Share | 0.150 | 0.150 | 0.150 | 0.150 | 0.300 |
Dividend Growth | - | - | - | -50.00% | 200.00% |
Gross Margin | 13.14% | 13.80% | 15.31% | 17.59% | 38.70% |
Operating Margin | 8.02% | 8.63% | 9.18% | 10.66% | 32.29% |
Profit Margin | 7.68% | 8.24% | 9.42% | 10.99% | 27.98% |
Free Cash Flow Margin | 8.36% | 6.43% | 2.86% | -0.14% | 14.17% |
EBITDA | 3,365 | 3,818 | 3,686 | 3,809 | 10,124 |
EBITDA Margin | 13.91% | 14.18% | 14.02% | 14.72% | 35.69% |
D&A For EBITDA | 1,426 | 1,493 | 1,272 | 1,049 | 963.3 |
EBIT | 1,939 | 2,325 | 2,414 | 2,760 | 9,161 |
EBIT Margin | 8.02% | 8.63% | 9.18% | 10.66% | 32.29% |
Effective Tax Rate | 12.29% | 11.41% | 5.33% | 10.67% | 13.33% |
Revenue as Reported | 24,198 | 26,931 | 26,298 | 25,884 | 28,367 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.